Study Stopped
The screening service moved to a pan-London service and the trial was not able to be continued.
Does the Wording of Text Message Reminders Improve Uptake in Breast Screening?
1 other identifier
interventional
7,944
1 country
1
Brief Summary
Breast screening is a service offered by the NHS to help detect breast cancer and precancerous changes early at a time when treatment is more likely to be curative. An effective service must reach the 'at risk' but asymptomatic population. Breast screening uptake in London, consistently falls below the national target and is well below the national average. Uptake in West London is particularly low, with boroughs in Inner North West London having the some of lowest uptake rates in the country. Routine text message reminders have proven effective at improving uptake of breast screening appointments. However little attention is paid to the content of the messages. Previous studies of text message reminders in other clinical areas have shown that the content of these messages matters and some text messages are more effective than others. This protocol describes the design of a randomized controlled trial to investigate the effect of differently worded text messages on the engagement with breast screening in West London. Two intervention arms were designed taking into consideration results of a 1000 woman survey to highlight the behavioural barriers that most predict attendance. The survey tested 15 behavioural constructs and the two that most strongly predicted history of attendance were used to inform the text message content of the intervention arms for this trial. To this end, this randomised controlled trial (RCT) will test the current standard practice text message reminder against two intervention text message trial arms informed by the above described survey. The setting is West of London Breast Screening Service and women aged 47-73 who are due for screening will be randomized to receive one of the three trial arms. The primary outcome is the difference in uptake between trial arms. Further statistical analysis will analyse the difference in uptake by age group, deprivation score and previous attendance status. Result will inform how small changes to the word content may have significant effects on attendance at screening mammogram appointments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable breast-cancer
Started Aug 2016
Shorter than P25 for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 19, 2016
CompletedStudy Start
First participant enrolled
August 9, 2016
CompletedFirst Posted
Study publicly available on registry
August 19, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 8, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
February 20, 2017
CompletedApril 11, 2019
April 1, 2019
3 months
July 19, 2016
April 9, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Uptake of the timed appointment provided by the screening service
Each patient is invited to an individual timed appointment. The outcome measure will be assessed based on if women attend their timed appointment. Usually this is within a month of the invitation letter being sent.
Usually within a month (Individual timed appointment is provided by the screening service)
Secondary Outcomes (4)
Uptake of time appointment by age group
Usually within a month (Individual timed appointment is provided by the screening service)
Uptake of timed appointment by number of previous invitations received
Usually within a month (Individual timed appointment is provided by the screening service)
Uptake of timed appointment by history of attendance
Usually within a month (Individual timed appointment is provided by the screening service)
Uptake of timed appointment by deprivation score
Usually within a month (Individual timed appointment is provided by the screening service)
Study Arms (3)
Control
NO INTERVENTIONThe current standard care text message reminder (SMS) that women routinely receive when being invited for their breast screening mammogram will be sent to the control group at 7 and 4 days before their timed appointment.
Intervention A - Behavioural Regulation
EXPERIMENTALIntervention A will be a text message reminder (SMS) containing a behavioural regulation message. Women will be sent this SMS at 7 and 4 days prior to their timed appointment.
Intervention B - Priority
EXPERIMENTALIntervention B will be a text message reminder (SMS) containing a priority message. Women will be sent this SMS at 7 and 4 days prior to their timed appointment.
Interventions
SMS reminder with 'Behavioural Regulation' message: 'Don't forget to make a diary note of your screening mammogram apt at (time)(date) at (site). Call 02033136644 to rearrange'
SMS reminder with 'Priority' message: 'Is your breast screening appointment on your priority list? Apt at (time), (date) at (site). Call 02033136644 to rearrange.'
Eligibility Criteria
You may qualify if:
- Women who are eligible and due for breast screening in West London.
You may not qualify if:
- Women who are not eligible for breast screening due to for example bilateral mastectomies.
- Women who have chosen to not have screening and have informed the screening centre or their GP.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Imperial College Healthcare NHS Trustlead
- Imperial College Londoncollaborator
Study Sites (1)
Department of Surgery and Cancer, St Mary's Campus, Praed Street, Imperial College London
London, W2 1NY, United Kingdom
Related Publications (1)
Palmer MJ, Henschke N, Villanueva G, Maayan N, Bergman H, Glenton C, Lewin S, Fonhus MS, Tamrat T, Mehl GL, Free C. Targeted client communication via mobile devices for improving sexual and reproductive health. Cochrane Database Syst Rev. 2020 Jul 14;8(8):CD013680. doi: 10.1002/14651858.CD013680.
PMID: 32779730DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sarah W Huf, MBBS BSc
Imperial College London
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 19, 2016
First Posted
August 19, 2016
Study Start
August 9, 2016
Primary Completion
November 8, 2016
Study Completion
February 20, 2017
Last Updated
April 11, 2019
Record last verified: 2019-04
Data Sharing
- IPD Sharing
- Will not share
There is no intention to make individual participant data available. Data will be analysed at aggregate level.